Characterization of Human Autoantibody Titers After Central Nervous System Insult

NCT03089749 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 63

Last updated 2023-04-14

No results posted yet for this study

Summary

The aim of the study is to quantitate Central Nervous System (CNS) autoantibody development in human blood using ELISA after human brain injury, spinal cord injury, and intra-axial brain surgeries.

Conditions

  • Brain Injuries, Traumatic
  • Spinal Cord Trauma
  • Intracranial Neoplasm

Sponsors & Collaborators

Principal Investigators

  • Gregory WJ Hawryluk, MD, Ph.D. · University of Utah

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2019-05-20
Completion
2019-05-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03089749 on ClinicalTrials.gov